ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AMGN Amgen Inc

269.98
0.60 (0.22%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Amgen Inc AMGN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.60 0.22% 269.98 23:00:03
Open Price Low Price High Price Close Price Previous Close
265.72 265.72 271.68 269.98 269.38
more quote information »

Recent News

Date Time Source Heading
4/26/202408:00PRNUSAMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION..
4/16/202416:26PRNUSAMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024
3/09/202411:20PRNUSAMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD..
3/08/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202416:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202416:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202416:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202416:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202415:00PRNUSAMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
2/29/202415:00PRNUSAMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE..
2/26/202408:00PRNUSAMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN..
2/19/202415:00PRNUSAMGEN TO HOST CONFERENCE CALL ON RARE DISEASE
2/14/202415:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/12/202418:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/09/202415:00PRNUSAMGEN TO PRESENT AT THE 34TH ANNUAL OPPENHEIMER HEALTHCARE..
2/07/202404:49IHMARKETNEWSMoody’s Downgrades NYCB to Junk Status, Ford Declares..
2/06/202416:05IHMARKETNEWSU.S. Stocks Finish Choppy Trading Day Modestly Higher
2/06/202415:20EDGAR2Form 8-K - Current report
2/06/202415:01PRNUSAMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL..
2/06/202405:27IHMARKETNEWSUS Index Futures Mixed, Oil Prices Edge Higher
2/02/202415:25IHMARKETNEWSU.S. Stocks Extend Thursday’s Rally On Upbeat Meta, Amazon..
2/01/202415:00PRNUSAMGEN ANNOUNCES WEBCAST OF 2023 FOURTH QUARTER AND FULL YEAR..
1/29/202404:00PRNCAdeCODE genetics: A sequence variant that increases risk of..
1/17/202405:33IHMARKETNEWSWall Street Highlights: Tesla Cuts Prices in Germany,..
1/10/202409:12DJNXeris Biopharma Shares Climb 12% on Amgen License Agreement
1/10/202407:53DJNXeris Biopharma Reaches License Agreement With Amgen On..
1/10/202407:45IHNWGLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons
1/03/202415:00PRNUSAMGEN TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE..
1/02/202410:42DJNAmgen On Pace for Record High Close -- Data Talk
12/26/202308:00PRNUSAMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS®..
12/19/202319:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
12/14/202308:53DJNAmgen Names James Bradner Chief Scientific Officer
12/14/202308:16EDGAR2Form 8-K - Current report
12/14/202308:00PRNUSAMGEN ANNOUNCES EXECUTIVE APPOINTMENTS TO ACCELERATE..
12/14/202304:00PRNUSAMGEN TO SPONSOR THE IRISH OPEN
12/13/202315:40DJNAmgen Gets FDA Priority Review For Lung Cancer Treatment
12/13/202315:00PRNUSFDA Grants Priority Review to Amgen's Tarlatamab Application..
12/13/202305:30IHMARKETNEWSCal-Maine Avian Flu Outbreak Impact, Amgen Hikes Dividend..
12/12/202315:41DJNAmgen Raises Dividend 5.6% To $2.25 A Share
12/12/202315:00PRNUSAMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO..
12/08/202308:00PRNUSAMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
12/04/202318:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/04/202318:40EDGAR2Form 144 - Report of proposed sale of securities
11/29/202319:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202315:00PRNUSAMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE

Your Recent History

Delayed Upgrade Clock